Pharma Focus Asia

ValGenesis Announces Strategic Partnership with Validator K.K. to Expand in Japan

Wednesday, July 03, 2024

ValGenesis Inc., a leading provider of enterprise validation lifecycle management systems (VLMS), has announced a strategic reseller partnership with Validator K.K., a reputable Japanese company known for its validation products and services. This collaboration leverages Validator’s on-site validation services to benefit the Japanese life sciences sector.

Established in 2015, Validator has earned recognition for its commitment to quality and continuous improvement, evidenced by its ISO9001 certification. Their innovative business model focuses on providing on-site validation services, which has been well-received by companies struggling to secure in-house validation staff, facing high travel costs, or requiring specialized expertise for equipment.

ValGenesis is a pioneer in the field of digitized validation, offering a platform that includes its flagship VLMS product. This platform is utilized in over 100,000 GMP systems worldwide, helping life sciences companies enhance their digital transformation strategies, ensure compliance, and standardize processes with a fully digital, risk-based validation approach.

Validator’s services address key issues in the pharmaceutical industry, making them a preferred partner in Japanese life sciences. As a reseller partner of ValGenesis in Japan, customers can benefit from Validator’s on-site services combined with ValGenesis's digital validation platform.

This partnership provides unique advantages to Validator’s customers, such as on-demand expertise with flexible scalability, comprehensive risk management, increased budget flexibility, and improved quality assurance.

“Japan is a critical market for ValGenesis, being the world’s second-largest pharma and medtech market and a key innovation center for the global life sciences industry. We are honored to enter this market through a reliable partner like Validator,” said Bo Olsen, SVP of Partners at ValGenesis. “With Validator’s on-site service model, customers can now access world-class solutions like ValGenesis VLMS, supporting digital transformation and adding value to validation and manufacturing processes. Our partnership with Validator offers a tailored approach to digitization for Japan’s unique conditions and industry needs.”

“We are excited about this collaboration with ValGenesis, a leader in validation lifecycle management systems. Although paper-based validation is still common in Japan, recent GMP audit updates are pushing its limits. This partnership allows us to meet customer and government requirements through ValGenesis VLMS,” said Tamura Hiroki, Representative Director of Validator K.K., Japan. “Japan’s leading position in the global pharmaceutical market is driven by relentless R&D and quality control efforts. With a shrinking population and labor shortage, productivity improvements are essential. Digital transformation is necessary for sustainable growth.”



magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference